Genetic Testing trials for Breast cancer

All Genetic Testing trials · All Breast cancer trials

Phase breakdown

Recruiting trials studying Genetic Testing for Breast cancer

• Adding an Immunotherapy Drug, MEDI4736 (Durvalumab), to the Usual Chemotherapy Treatment (Paclitaxel, Cyclophosphamide, and Doxorubicin) for Stage II-III Breast Cancer
  NCT06058377 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · 554 locations
• Cancer Genetic Testing in Ethnic Populations
  NCT04475640 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · 2 locations
• Identifying and Caring for Individuals With Inherited Cancer Syndrome
  NCT04494945 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · 2 locations

Common questions

How many trials study Genetic Testing for Breast cancer?

3 recruiting trials.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.